InVivo Therapeutics Holdings Corp (NVIVQ)

[sons4]

The potential market for this company is unbelieveable!! Buy some shares and leave the computer for a year is my recommendation, if things go well the sky is the limit here!!

http://seekingalpha.com/article/495961-big-step-forward-for-invivo?source=yahoo

We see an enormous opportunity for the injectable hydrogel. The acute and chronic spinal cord injury market is estimated at $20 to $25 billion in the U.S. alone. For peripheral nerve pain, there are an estimated 3.2 million nerve block injections done in the U.S. each year. It's an estimated $15 billion market. Existing treatment options are limited and only curb pain for as little as one week. A localized injection using the hydrogel to provide time-released anti-inflammatory therapies like methylprednisolone could provide pain relief for up to twelve months with limited systemic side-effects.

Recommendation

InVivo's stock is up 5% this morning on the announcement. We do not think the market has come to grips with the potential here. Moving the scaffolding forward under HDE is enormous, and the FDA seems clearly supportive of the company's plans. Hydrogel data is expected soon, and between spinal cord injury and peripheral nerve pain, InVivo is sitting on two potential blockbuster indications.